Enzomenib
Enzomenib (DSP5336) is a small molecule menin-MLL interaction inhibitor used in hematological malignancy research. It has demonstrated activity in both in vitro assays and in vivo models of acute leukemia driven by MLL rearrangements or NPM1 mutations.
Product Specifications
CAS Number
2412555-70-3
Field of Research
Epigenetics & Chromatin
Smiles
C (=O) (N1CCC2 (CN (C2) C=3C (OC4=C (C (N (C (C) C) C (C) C) =O) C=C (F) C=C4) =CN=CN3) CC1) [C@@H]5[C@]6 (C (=C) C[C@@] (N5) (CC6) [H]) [H]
Molecular Formula
C33H43FN6O3
Molecular Weight
590.73
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6274511-01 0.2 mL
APOL6, ID (APOL6, Apolipoprotein L6, Apolipoprotein L-VI) (AP)
Sign In for Pricing
View Details MBS6274511-02 5x 0.2 mL
APOL6, ID (APOL6, Apolipoprotein L6, Apolipoprotein L-VI) (AP)
Sign In for Pricing
View Details 
124743 50 µg
CDC2L6 (CDK19, CDK11, KIAA1028, Cyclin-dependent Kinase 19, CDC2-related Protein Kinase 6, Cell Division Cycle 2-like Protein Kinase 6, Cell Division Protein Kinase 19, Cyclin-dependent Kinase 11, Death-preventing Kinase, bA346C16.3)
Sign In for Pricing
View Details 583502-01 20 µg
Actin, Cytoplasmic 1, Recombinant, Human, aa1-375, His-Tag, Myc-Tag
Sign In for Pricing
View Details